FDC Limited
FDC Limited (FDC) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 486 Cr | 458 Cr | 462 Cr | 638 Cr | 514 Cr | 464 Cr | 492 Cr | 648 Cr | 473 Cr | 465 Cr | 585 Cr | 668 Cr |
| Operating expenses (approx.) | 410 Cr | 374 Cr | 406 Cr | 492 Cr | 444 Cr | 417 Cr | 438 Cr | 508 Cr | 439 Cr | 412 Cr | 478 Cr | 525 Cr |
| EBITDA | 76 Cr | 84 Cr | 56 Cr | 147 Cr | 70 Cr | 47 Cr | 54 Cr | 140 Cr | 34 Cr | 52 Cr | 106 Cr | 143 Cr |
| OPM % | 15.7% | 18.3% | 12.2% | 23.0% | 13.7% | 10.1% | 11.0% | 21.6% | 7.1% | 11.2% | 18.2% | 21.4% |
| Other income | 27 Cr | 25 Cr | 20 Cr | 28 Cr | 35 Cr | 19 Cr | 16 Cr | 36 Cr | 21 Cr | 21 Cr | 50 Cr | 48 Cr |
| Interest | 1 Cr | 0.97 Cr | 0.95 Cr | 1 Cr | 1 Cr | 0.95 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 2 Cr | 0.83 Cr |
| Depreciation | 10 Cr | 10 Cr | 10 Cr | 11 Cr | 14 Cr | 13 Cr | 16 Cr | 15 Cr | 15 Cr | 15 Cr | 14 Cr | 15 Cr |
| Profit before tax | 93 Cr | 98 Cr | 65 Cr | 163 Cr | 90 Cr | 51 Cr | 53 Cr | 160 Cr | 38 Cr | 36 Cr | 140 Cr | 175 Cr |
| Tax % | 24.7% | 18.8% | 29.0% | 26.9% | 20.0% | 27.6% | 27.5% | 24.0% | 25.5% | 22.2% | 26.3% | 24.2% |
| Net profit | 70 Cr | 79 Cr | 46 Cr | 119 Cr | 72 Cr | 37 Cr | 39 Cr | 121 Cr | 28 Cr | 28 Cr | 103 Cr | 132 Cr |
| EPS (₹) | ₹4.22 | ₹4.86 | ₹2.84 | ₹7.31 | ₹4.43 | ₹2.28 | ₹2.38 | ₹7.45 | ₹1.75 | ₹1.74 | ₹6.35 | ₹8.14 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,083 Cr | 1,344 Cr | 1,333 Cr | 1,528 Cr | 1,784 Cr | 1,943 Cr | 2,108 Cr | 2,171 Cr | Sign in for TTM |
| Operating expenses (approx.) | 856 Cr | 1,051 Cr | 999 Cr | 1,274 Cr | 1,533 Cr | 1,604 Cr | 1,783 Cr | 1,825 Cr | Sign in for TTM |
| EBITDA | 227 Cr | 293 Cr | 334 Cr | 254 Cr | 251 Cr | 339 Cr | 325 Cr | 346 Cr | Sign in for TTM |
| OPM % | 20.9% | 21.8% | 25.1% | 16.6% | 14.1% | 17.4% | 15.4% | 15.9% | Sign in for TTM |
| Other income | 51 Cr | 69 Cr | 97 Cr | 76 Cr | 50 Cr | 102 Cr | 91 Cr | 114 Cr | Sign in for TTM |
| Interest | 1 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 4 Cr | 5 Cr | 5 Cr | Sign in for TTM |
| Depreciation | 35 Cr | 37 Cr | 38 Cr | 37 Cr | 39 Cr | 40 Cr | 54 Cr | 59 Cr | Sign in for TTM |
| Profit before tax | 241 Cr | 320 Cr | 388 Cr | 289 Cr | 258 Cr | 396 Cr | 357 Cr | 375 Cr | Sign in for TTM |
| Tax % | 27.9% | 25.0% | 22.3% | 25.3% | 24.8% | 23.0% | 25.3% | 24.9% | Sign in for TTM |
| Net profit | 174 Cr | 240 Cr | 301 Cr | 216 Cr | 194 Cr | 305 Cr | 267 Cr | 281 Cr | Sign in for TTM |
| EPS (₹) | ₹9.76 | ₹13.94 | ₹17.72 | ₹12.81 | ₹11.66 | ₹18.58 | ₹16.39 | ₹17.29 | Sign in for TTM |
| Dividend payout % | — | — | — | -0.1% | 0.0% | 0.0% | 30.4% | 28.8% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 18 Cr | 17 Cr | 17 Cr | 17 Cr | 17 Cr | 16 Cr | 16 Cr | 16 Cr |
| Reserves | 1,428 Cr | 1,530 Cr | 1,717 Cr | 1,940 Cr | 1,965 Cr | 2,081 Cr | 2,265 Cr | 2,469 Cr |
| Borrowings | 0.49 Cr | 10 Cr | 0.60 Cr | 0.75 Cr | 0.64 Cr | 0.28 Cr | 0.11 Cr | — |
| Other liabilities | 194 Cr | 256 Cr | 222 Cr | 313 Cr | 361 Cr | 371 Cr | 433 Cr | 434 Cr |
| Total liabilities | 1,640 Cr | 1,813 Cr | 1,956 Cr | 2,270 Cr | 2,343 Cr | 2,468 Cr | 2,714 Cr | 2,919 Cr |
| Fixed assets (net) | 676 Cr | 667 Cr | 670 Cr | 667 Cr | 695 Cr | 677 Cr | 848 Cr | 952 Cr |
| CWIP | 12 Cr | 24 Cr | 19 Cr | 105 Cr | 198 Cr | 261 Cr | 136 Cr | 96 Cr |
| Investments | 585 Cr | 665 Cr | 790 Cr | 885 Cr | 806 Cr | 843 Cr | 1,028 Cr | 1,048 Cr |
| Loans & advances | 0.73 Cr | 1 Cr | 1 Cr | 0.55 Cr | 0.65 Cr | 1 Cr | 1 Cr | 0.95 Cr |
| Inventories | 174 Cr | 210 Cr | 215 Cr | 305 Cr | 329 Cr | 389 Cr | 375 Cr | 355 Cr |
| Trade receivables | 88 Cr | 124 Cr | 111 Cr | 82 Cr | 123 Cr | 117 Cr | 109 Cr | 152 Cr |
| Cash & bank | 20 Cr | 30 Cr | 30 Cr | 38 Cr | 24 Cr | 25 Cr | 51 Cr | 49 Cr |
| Other assets | 85 Cr | 92 Cr | 120 Cr | 187 Cr | 169 Cr | 155 Cr | 165 Cr | 266 Cr |
| Total assets | 1,640 Cr | 1,813 Cr | 1,956 Cr | 2,270 Cr | 2,343 Cr | 2,468 Cr | 2,714 Cr | 2,919 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 162 Cr | 155 Cr | 221 Cr | 318 Cr | 200 Cr |
| Cash from investing | — | — | — | -145 Cr | 11 Cr | -17 Cr | -200 Cr | -110 Cr |
| Cash from financing | — | — | — | -10 Cr | -180 Cr | -202 Cr | -92 Cr | -93 Cr |
| Net cash flow | — | — | — | 7 Cr | -14 Cr | 2 Cr | 26 Cr | -3 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 29 Cr | 42 Cr | 127 Cr | 221 Cr | 14 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 16.7% | 20.9% | 22.6% | 14.9% | 13.2% | 19.1% | 15.9% | 15.3% |
| ROE % | 12.0% | 15.5% | 17.4% | 0.4% | 9.8% | 14.6% | 11.7% | 11.3% |
| Debtor days | 29 | 34 | 30 | 20 | 25 | 22 | 19 | 25 |
| Inventory days | 231 | 226 | 226 | 244 | 204 | 243 | 235 | 224 |
| Days payable | 103 | 127 | 81 | 110 | 111 | 116 | 128 | 131 |
| Cash conversion cycle | 157 | 133 | 175 | 154 | 118 | 149 | 125 | 119 |
| Debt / equity | 0.0003 | 0.00 | 0.0003 | 0.0004 | 0.0003 | 0.0001 | 0.0000 | — |
| Current ratio | 4.13 | 3.76 | 4.56 | 3.68 | 3.42 | 3.58 | 3.00 | 3.11 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -0.09 | -0.07 | -0.16 | -0.14 |
Compare with peers
Loading peers…